Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase

(2018) Matthew Ezewudo et al.   Scientific Reports

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

(2017) Paolo Miotto et al.   EUROPEAN RESPIRATORY JOURNAL

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey

(2017) Elisa Tagliani et al.   Scientific Reports

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

(2016) Rebecca E. Colman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

(2015) Rebecca E. Colman et al.   PLoS One

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

(2014) Naomi Hillery et al.   Trials

Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations

(2013) T. C. Rodwell et al.   JOURNAL OF CLINICAL MICROBIOLOGY